Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer

Matthew James Walton; Mark Stephen Corbett; Kerry Dwan; Martin Wanyoike Njoroge; Helen Athena Fulbright; Noortje Uphoff; Robert Hodgson; Sofia Dias

Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer

Matthew James Walton, Mark Stephen Corbett, Kerry Dwan, Martin Wanyoike Njoroge, Helen Athena Fulbright, Noortje Uphoff, Robert Hodgson, Sofia Dias

Centre for Reviews and Dissemination

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 11 May 2023

Access to Document

https://www.nice.org.uk/guidance/ta898/documents/committee-papers

Cite this

@book{50c8030cf4cd486bae583a245986d609,

title = "Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer",

author = "Walton, {Matthew James} and Corbett, {Mark Stephen} and Kerry Dwan and Njoroge, {Martin Wanyoike} and Fulbright, {Helen Athena} and Noortje Uphoff and Robert Hodgson and Sofia Dias",

year = "2023",

month = may,

day = "11",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer

AU - Walton, Matthew James

AU - Corbett, Mark Stephen

AU - Dwan, Kerry

AU - Njoroge, Martin Wanyoike

AU - Fulbright, Helen Athena

AU - Uphoff, Noortje

AU - Hodgson, Robert

AU - Dias, Sofia

PY - 2023/5/11

Y1 - 2023/5/11

M3 - Commissioned report

BT - Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer

PB - National Institute for Health and Care Excellence

ER -